Advisory Board

Fabiana Arduini is a Full Professor at Department of Chemical Science and Technologies, University of Rome “Tor Vergata”, founder of start-up SENSE4MED, DG at ISO9001 Certified Laboratory LabCap, University of Rome “Tor Vergata”, Editor of Green Analytical Chemistry Journal, Elsevier, Associated Editor of Microchemical Journal, Elsevier, Specialty Chief Editor Micro- and Nano- Sensors, Frontiers in Sensors, one of the seven relevant scientists selected by Italian Ministry of Defence for studies on depleted uranium, and Coordinator of Italian Sensor Group, Italian Chemical Society 2019-2021. Her research activity deals with the development of miniaturised electrochemical devices mainly using screen-printed electrodes modified with nanomaterials and paper-based analytical tools applied in environmental, biomedical, agrifood, and defense sectors, with over 150 articles published in peer-review journals, H index 56, Scopus source, > 5 patents, coordinators of several national/international projects including Horizon Europe Pathfinder project Phoenix-OoC (March 2024- February 2027). Her name is listed in the top 2% of most cited researchers in the world.

Dr. Boada is the co-founder and medical director of the Ace Alzheimer Center Barcelona. A distinguished professor at the Universitat Internacional de Catalunya, she is a member of the Executive Committee of the European Alzheimer’s Disease Consortium (EADC) and PI for the Ace Group of the CIBERNED. Dr. Boada’s impact extends beyond national borders, leading projects granted by the European Community such as MOPEAD. She has also promoted grant projects such as GR@ACE, the FACEHBI cohort, NORFACE, and TARTAGLIA. She has led about 150 Clinical Trials and has authored more than 550 scientific articles. In recognition of her contributions to Alzheimer’s disease research, the Generalitat of Catalunya (Catalan Government) awarded her the Creu de Sant Jordi in 2016.

Oliver Smith is the Founder and Director of Daedalus Futures, a Responsible AI consultancy that supports organisations to create strategic advantage by using AI responsibly. He was one of the founding executive team at Koa Health, which span out of Telefonica Alpha in 2020 with a €50m Series A, where he was responsible for strategy and ethics. Prior to Koa Health he was Director of Strategy and Innovation at Guy’s and St Thomas’ Charity, responsible for investing £100m over five years in innovations across acute, primary, and integrated care, biomedical research and digital health start-ups. He was a Senior Civil Servant in the UK Department of Health; responsible for UK Tobacco Control Policy, and UK Obesity Policy before that, writing the government’s first comprehensive childhood obesity strategy. Oliver was also a Policy Adviser in the Prime Minister’s Strategy Unit under Tony Blair. He has an MA in Politics, Philosophy, and Economics from Oxford University.

Charlotte Teunissen (full professor in Neurochemistry) aims to improve care of patients with neurological diseases by developing body fluid biomarkers for diagnosis, stratification, prognosis and monitoring treatment responses. Studies of her research group span the entire spectrum of biomarker development, starting with biomarker identification, followed by assay development and validation, and extensive clinical validation to ultimately implement novel biomarkers in clinical practice.

She is responsible for the Alzheimer Center Amsterdam body fluid and leads several international biomarker networks, such as the CSF Society and the Alzheimer Association-Global Biomarker Standardization consortium, and the recently founded Coral proteomics consortium. She is the coordinator of the Marie Curie MIRIADE project, aiming to train 15 novel researchers into accelerate dementia biomarker development.

Jiří spent 5 years as a Partner and Director at UNICO.AI and established the incubation IPL Ventures. Prior to this, he gained extensive experience in creating and advising early-stage technology spin-offs and startups, particularly those originating from intellectual property developed at universities. This experience began at Imperial Innovations, a London-based technology commercialization and investment company. Jiří holds two doctorate degrees, one in Organic Electronics from Brno University of Technology and the other in Biophysics from the Czech Academy of Sciences.

Maria del Puerto Morales is a Professor at the Institute of Material Science in Madrid (ICMM/CSIC) and the leader of the MaMBIO group, specializing in nanotechnology for biological applications.

She has made significant contributions to the field, including developing new methods for detecting and quantifying magnetic nanoparticles.

Her work also focuses on creating magnetic nanoparticles with enhanced properties for medical uses, like hyperthermia therapy and remote-controlled drug release.

With over 300 articles, 14 book chapters, and 9 patents, she’s well-regarded in her field and has received recognition from various organizations. She’s also involved in supervising students and engaging in outreach activities to share her knowledge with the public.

Winnie Svendsen is a full professor at the Department of Biotechnology and Biomedicine at the Technical University of Denmark and leads the Nano Bio Integrated Systems (NaBIS) group. Trained as an experimental physicist in Dublin, Ireland, her research focuses on developing advanced nanotechnological systems for improved diagnostics and monitoring, including novel binders for enhanced analytical sensor performance. Winnie has vast entrepreneurial experience being the founder of seven companies, the latest being Hei Therapeutic, which aims to empower thyroid patients to manage their own disease.

Georgios Theodoridis is a Professor of Analytical Chemistry in the Department of Chemistry at Aristotle University of Thessaloniki, Greece. He studied Chemistry and received his PhD in separation sciences from Aristotle University. He has worked at the Universities of Pardubice and Leiden, AstraZeneca UK (2006-2007), and IASMA, Edmund Mach Foundation, Trento, Italy (2009-2010). His research focuses on the application of LC-MS and GC-MS in metabolite profiling and bioanalysis. He leads the BIOMIC initiative at Aristotle University and the FoodOmicsGR National Research Infrastructure. He has co-authored approximately 230 peer-reviewed articles, 20 book chapters, and has made more than 150 presentations at international meetings. He serves as an Editor of the Journal of Chromatography B and is on the editorial boards of Metabolites, Open Journal of Biochemistry, Journal of Integrated Omics, and Separations. He is a recipient of international awards and distinctions, including being listed on the Analytical Scientist Power List 2023. He is also a co-founder of ThetaBiomarkers, a spinoff company developing cutting-edge bioanalytical solutions in life sciences, nutrition, and wellness.

Leonidas Chouliaras is an Assistant Professor and Consultant in Old Age Psychiatry at the Department of Psychiatry, University of Cambridge and at Essex Partnership University NHS Foundation Trust (EPUT). He is also a Clinical Hub Advisor at the Early Detection of Neurodegenerative Diseases (EDON) initiative and the Interim Head of Research at EPUT. His undergraduate training was at the Aristotle University of Thessaloniki in Greece and subsequently completed his PhD at the University of Maastricht in the Netherlands. He trained in psychiatry at Oxford and Cambridge before moving to his current post in 2023. He splits his time between clinical work in a dementia and old age psychiatry service and research on the role of epigenetic mechanisms and blood biomarkers in neurodegeneration and particularly in Lewy Body Dementia.